EP. 109 - Blood Cancer patients recently have been waiting for the medications they desperately need, due to current drug shortages. A new unique partnership is now helping to ease those challenges.

On this episode, I am joined by Abizer Gaslightwala, vice president, head of U.S. hematology and oncology at Jazz Pharmaceuticals and Dr. Rachel Rau, Assistant Professor at Baylor College of Medicine, to discuss some common causes and impacts of drug shortages, as well as unique approaches to collaboration during drug development to ensure reliable access to treatment for patients, specifically with certain rare forms of leukemia and lymphoma.

Please subscribe and rate our show!